Skip to content
NeuroTechGuide

Single-day TMS course shows early promise for bipolar depression in a 30-person case series

Researchers from Salience TMS and Ampa report response and remission rates after 20 short TMS sessions in one day, but the study had no control group.

In briefNeuromodulationResearch

A case series published in Transcranial Magnetic Stimulation, the journal of the Clinical TMS Society, tested a one-day course of TMS in 30 adults with bipolar I depression. Each person received 20 three-minute sessions about 20 minutes apart, plus a single dose of the drug D-cycloserine. Researchers from Salience TMS Neuro Solutions and Palo Alto company Ampa say all participants finished the regimen, with no serious side effects and no switches into mania. At six weeks, 73.3% met response criteria and 43.3% met remission criteria on a standard depression scale.

Standard TMS takes several weeks of daily visits. The study was small and uncontrolled, and the authors call the results preliminary until randomized trials are done.

Learn more: TMS · Ampa’s portable TMS system

Share:XLinkedInBlueskyEmail

More news